.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

REZULIN Drug Profile

« Back to Dashboard
Rezulin is a drug marketed by Pfizer Pharms and is included in one NDA.

The generic ingredient in REZULIN is troglitazone. Additional details are available on the troglitazone profile page.

Summary for Tradename: REZULIN

Patents:0
Applicants:1
NDAs:1

Clinical Trials for: REZULIN

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-001Jan 29, 1997DISCNNo<disabled><disabled>
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-003Aug 4, 1997DISCNNo<disabled><disabled>
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-002Jan 29, 1997DISCNNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: REZULIN

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-003Aug 4, 19975,602,133<disabled>
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-002Jan 29, 19975,457,109<disabled>
Pfizer Pharms
REZULIN
troglitazone
TABLET;ORAL020720-003Aug 4, 19975,104,888<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc